JP2021511047A5 - - Google Patents
Info
- Publication number
- JP2021511047A5 JP2021511047A5 JP2020539779A JP2020539779A JP2021511047A5 JP 2021511047 A5 JP2021511047 A5 JP 2021511047A5 JP 2020539779 A JP2020539779 A JP 2020539779A JP 2020539779 A JP2020539779 A JP 2020539779A JP 2021511047 A5 JP2021511047 A5 JP 2021511047A5
- Authority
- JP
- Japan
- Prior art keywords
- itr
- sense
- item
- expression cassette
- stranded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023116157A JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
| JP2025084944A JP2025113389A (ja) | 2018-01-19 | 2025-05-21 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862619392P | 2018-01-19 | 2018-01-19 | |
| US62/619,392 | 2018-01-19 | ||
| PCT/US2019/014122 WO2019143885A1 (en) | 2018-01-19 | 2019-01-18 | Closed-ended dna vectors obtainable from cell-free synthesis and process for obtaining cedna vectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023116157A Division JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021511047A JP2021511047A (ja) | 2021-05-06 |
| JP2021511047A5 true JP2021511047A5 (enExample) | 2022-02-24 |
Family
ID=67301565
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539779A Pending JP2021511047A (ja) | 2018-01-19 | 2019-01-18 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
| JP2023116157A Withdrawn JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
| JP2025084944A Pending JP2025113389A (ja) | 2018-01-19 | 2025-05-21 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023116157A Withdrawn JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
| JP2025084944A Pending JP2025113389A (ja) | 2018-01-19 | 2025-05-21 | 無細胞合成から得ることができる閉端ＤＮＡベクターおよびｃｅＤＮＡベクターを得るためのプロセス |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US12442015B2 (enExample) |
| EP (1) | EP3740571A4 (enExample) |
| JP (3) | JP2021511047A (enExample) |
| KR (2) | KR102879598B1 (enExample) |
| CN (1) | CN111868242A (enExample) |
| AU (1) | AU2019210034B2 (enExample) |
| BR (1) | BR112020013319A2 (enExample) |
| CA (1) | CA3088984A1 (enExample) |
| IL (1) | IL275878B2 (enExample) |
| MA (1) | MA51626A (enExample) |
| MX (1) | MX2020005790A (enExample) |
| MY (1) | MY208589A (enExample) |
| PH (1) | PH12020550878A1 (enExample) |
| SG (1) | SG11202005271TA (enExample) |
| UA (1) | UA130154C2 (enExample) |
| WO (1) | WO2019143885A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020002394A2 (pt) | 2017-08-09 | 2020-07-28 | Bioverativ Therapeutics Inc. | moléculas de ácidos nucleicos e usos das mesmas |
| MA51842A (fr) * | 2018-02-14 | 2020-12-23 | Generation Bio Co | Vecteurs d'adn non viraux et utilisations associées pour la production d'anticorps et de protéines de fusion |
| KR102925832B1 (ko) | 2018-08-09 | 2026-02-11 | 바이오버라티브 테라퓨틱스 인크. | 핵산 분자 및 비바이러스 유전자 치료를 위한 이의 용도 |
| AU2019376663A1 (en) * | 2018-11-09 | 2021-06-24 | Generation Bio Co. | Modified closed-ended DNA (ceDNA) comprising symmetrical modified inverted terminal repeats |
| GB201905651D0 (en) | 2019-04-24 | 2019-06-05 | Lightbio Ltd | Nucleic acid constructs and methods for their manufacture |
| CA3147414A1 (en) | 2019-07-17 | 2021-01-21 | Generation Bio Co. | Synthetic production of single-stranded adeno associated viral dna vectors |
| DE102020111571A1 (de) | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
| AU2021244555A1 (en) * | 2020-03-24 | 2022-11-24 | Generation Bio Co. | Non-viral dna vectors and uses thereof for expressing factor ix therapeutics |
| WO2022023284A1 (en) * | 2020-07-27 | 2022-02-03 | Anjarium Biosciences Ag | Compositions of dna molecules, methods of making therefor, and methods of use thereof |
| US20220243201A1 (en) * | 2020-08-23 | 2022-08-04 | Bioverativ Therapeutics Inc. | Engineered itr sequences and methods of use |
| EP4214309A4 (en) * | 2020-09-16 | 2025-07-16 | Generation Bio Co | CLOSED-END DNA VECTORS AND RELATED USES FOR EXPRESSING PHENYLALANINE HYDROXYLASE (PAH) |
| GB202014751D0 (en) | 2020-09-18 | 2020-11-04 | Lightbio Ltd | Targeting vector |
| GB202014772D0 (en) | 2020-09-18 | 2020-11-04 | Lightbio Ltd | Nucleic acid construct |
| TW202246499A (zh) * | 2021-01-25 | 2022-12-01 | 美商普維爾治療公司 | 以腺相關病毒（ａａｖ）為基礎的基因表現之調節 |
| CN112980862A (zh) * | 2021-02-25 | 2021-06-18 | 通用生物系统（安徽）有限公司 | 一种高纯度微环dna的制备方法 |
| US20240358852A1 (en) | 2021-04-20 | 2024-10-31 | Anjarium Biosciences Ag | Compositions of dna molecules encoding amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase, methods of making thereof, and methods of use thereof |
| EP4329884A1 (en) * | 2021-04-27 | 2024-03-06 | Generation Bio Co. | Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof |
| WO2022232289A1 (en) * | 2021-04-27 | 2022-11-03 | Generation Bio Co. | Non-viral dna vectors expressing therapeutic antibodies and uses thereof |
| KR20240005903A (ko) * | 2021-05-07 | 2024-01-12 | 제너레이션 바이오 컴퍼니 | 백신 전달을 위한 비바이러스성 dna 벡터 |
| US20240261395A1 (en) * | 2021-05-07 | 2024-08-08 | Generation Bio Co. | Lyophilized non-viral dna vector compositions and uses thereof |
| CN118489008A (zh) * | 2021-12-23 | 2024-08-13 | 世代生物公司 | 封闭端dna载体的可扩展且高纯度无细胞合成 |
| JP2025504404A (ja) | 2022-01-14 | 2025-02-12 | アンジャリウム バイオサイエンシズ エージー | Ｖｉｉｉ因子をコードするｄｎａ分子の組成物、それを作製する方法、及びその使用方法 |
| GB202204112D0 (en) | 2022-03-23 | 2022-05-04 | Lightbio Ltd | Linear construct |
| EP4293101A1 (en) | 2022-06-14 | 2023-12-20 | Asklepios Biopharmaceutical, Inc. | Reactor with temperature control and method of using the same |
| EP4558637A2 (en) | 2022-07-19 | 2025-05-28 | Rampart Bioscience, Inc. | Non-immunogenic circular, non-viral dna vectors |
| US20260055426A1 (en) | 2022-08-19 | 2026-02-26 | Generation Bio Co. | CLEAVABLE CLOSED-ENDED DNA (ceDNA) AND METHODS OF USE THEREOF |
| WO2024119017A1 (en) * | 2022-12-01 | 2024-06-06 | Generation Bio Co. | Synthetic single stranded nucleic acid compositions and methods thereof |
| WO2024170778A1 (en) | 2023-02-17 | 2024-08-22 | Anjarium Biosciences Ag | Methods of making dna molecules and compositions and uses thereof |
| US11993783B1 (en) | 2023-03-27 | 2024-05-28 | Genecraft Inc. | Nucleic acid molecule comprising asymmetrically modified ITR for improving expression rate of inserted gene, and use thereof |
| WO2026085495A1 (en) | 2024-10-18 | 2026-04-23 | Generation Bio Co. | Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US6346415B1 (en) | 1997-10-21 | 2002-02-12 | Targeted Genetics Corporation | Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors |
| EP1463761A1 (en) | 2001-11-30 | 2004-10-06 | Innogenetics N.V. | Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| JP4997253B2 (ja) | 2007-08-10 | 2012-08-08 | Ｔｏｔｏ株式会社 | 組換え哺乳動物細胞、組換え哺乳動物細胞の製造方法、および目的タンパク質の生産方法 |
| US8709778B2 (en) * | 2008-10-28 | 2014-04-29 | Xavier Danthinne | Method of adenoviral vector synthesis |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| EP3517612A1 (en) | 2013-03-15 | 2019-07-31 | The University of North Carolina At Chapel Hill | Synthetic adeno-associated virus inverted terminal repeats |
| SG10201913688TA (en) * | 2016-03-03 | 2020-03-30 | Univ Massachusetts | Closed-ended linear duplex dna for non-viral gene transfer |
| AU2018371063C1 (en) | 2017-11-21 | 2025-04-17 | 4basebio Sl | Methods and kits for amplification of double stranded DNA |
| MA51842A (fr) * | 2018-02-14 | 2020-12-23 | Generation Bio Co | Vecteurs d'adn non viraux et utilisations associées pour la production d'anticorps et de protéines de fusion |
| MX2021008874A (es) * | 2019-01-24 | 2021-08-19 | Generation Bio Co | Adn de extremo cerrado (ceadn) y uso en metodos de reduccion de la respuesta inmunitaria relacionada con tratamiento genico o de acido nucleico. |
| CA3147414A1 (en) * | 2019-07-17 | 2021-01-21 | Generation Bio Co. | Synthetic production of single-stranded adeno associated viral dna vectors |
| US20220228171A1 (en) * | 2019-07-17 | 2022-07-21 | Generation Bio Co. | Compositions and production of nicked closed-ended dna vectors |
-
2019
- 2019-01-18 US US16/962,005 patent/US12442015B2/en active Active
- 2019-01-18 MA MA051626A patent/MA51626A/fr unknown
- 2019-01-18 SG SG11202005271TA patent/SG11202005271TA/en unknown
- 2019-01-18 CN CN201980019414.XA patent/CN111868242A/zh active Pending
- 2019-01-18 EP EP19741445.1A patent/EP3740571A4/en active Pending
- 2019-01-18 JP JP2020539779A patent/JP2021511047A/ja active Pending
- 2019-01-18 MX MX2020005790A patent/MX2020005790A/es unknown
- 2019-01-18 CA CA3088984A patent/CA3088984A1/en active Pending
- 2019-01-18 AU AU2019210034A patent/AU2019210034B2/en active Active
- 2019-01-18 KR KR1020207023526A patent/KR102879598B1/ko active Active
- 2019-01-18 KR KR1020257036119A patent/KR20250159738A/ko active Pending
- 2019-01-18 UA UAA202005240A patent/UA130154C2/uk unknown
- 2019-01-18 BR BR112020013319-1A patent/BR112020013319A2/pt unknown
- 2019-01-18 MY MYPI2020003241A patent/MY208589A/en unknown
- 2019-01-18 WO PCT/US2019/014122 patent/WO2019143885A1/en not_active Ceased
- 2019-01-18 IL IL275878A patent/IL275878B2/en unknown
-
2020
- 2020-06-11 PH PH12020550878A patent/PH12020550878A1/en unknown
-
2023
- 2023-07-14 JP JP2023116157A patent/JP2023126487A/ja not_active Withdrawn
-
2025
- 2025-05-21 JP JP2025084944A patent/JP2025113389A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023126487A5 (enExample) | ||
| US12600984B2 (en) | Viral and non-viral nanoplasmid vectors with improved production | |
| JP2022530544A5 (enExample) | ||
| CA3233336A1 (en) | Circular rna and preparation method thereof | |
| KR20240113624A (ko) | Aav 캡시드 변이체 및 이의 용도 | |
| JP2022530633A5 (enExample) | ||
| EP4476241A1 (en) | Aav capsid variants and uses thereof | |
| JP2022530656A5 (enExample) | ||
| CA3092459A1 (en) | Closed-ended dna (cedna) vectors for insertion of transgenes at genomic safe harbors (gsh) in humans and murine genomes | |
| JP7481755B2 (ja) | 組換えパルボウイルスベクターならびにその作製および使用方法 | |
| JP2022529065A5 (enExample) | ||
| WO2022159402A1 (en) | Composition and method for high-multiplexed genome engineering using synthetic crispr arrays | |
| JP7489112B2 (ja) | Ｃｒｉｓｐｒタイプｉ－ｄシステムを利用した標的配列改変技術 | |
| WO2025102994A1 (zh) | 基于i型内含子的rna体外环化与滚环翻译的方法及其应用 | |
| CA3206298A1 (en) | Functional nucleic acid molecule and method | |
| US9012620B2 (en) | DNA constructs for specific inhibition of gene expression by RNA interference | |
| CN113950530A (zh) | 核酸多联体产物的表达 | |
| AU2022399440A1 (en) | Functional aav capsids for intravitreal administration | |
| JP2024521750A5 (enExample) | ||
| AU784832B2 (en) | Self-cleaving RNA sequences and their use for the control of protein synthesis | |
| JP2025510714A (ja) | 遺伝子編集用のｒｎａフレームワーク及び遺伝子編集方法 | |
| RU2020127017A (ru) | ДНК-ВЕКТОРЫ С ЗАМКНУТЫМИ КОНЦАМИ, ПОЛУЧАЕМЫЕ ПУТЕМ БЕСКЛЕТОЧНОГО СИНТЕЗА, И СПОСОБ ПОЛУЧЕНИЯ зкДНК-ВЕКТОРОВ | |
| JP7860174B2 (ja) | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター | |
| US20260103702A1 (en) | Compositions and methods for crispr modulation | |
| WO2025072763A2 (en) | Compositions and methods for precision editing with cas dimers |